Bio-Rad Laboratories Inc.

NYSE: BIO · Real-Time Price · USD
285.79
-1.42 (-0.49%)
At close: Aug 15, 2025, 3:59 PM
285.66
-0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bio-Rad Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
488.1M 403.8M 434.21M 470.78M
Short-Term Investments
1.18B 1.2B 1.36B 399.13M
Long-Term Investments
4.84B 7.7B 8.83B 14.39B
Other Long-Term Assets
101.9M 94.9M 94.6M 104.19M
Receivables
452.5M 489M 494.64M 423.54M
Inventory
760M 780.5M 719.32M 572.24M
Other Current Assets
30.7M 31.7M 29.16M 15.65M
Total Current Assets
3.03B 3.05B 3.16B 1.99B
Property-Plant & Equipment
688.6M 723.7M 679.55M 716.44M
Goodwill & Intangibles
704.1M 734.1M 738.6M 601.2M
Total Long-Term Assets
6.33B 9.25B 10.34B 15.81B
Total Assets
9.36B 12.3B 13.5B 17.8B
Account Payables
122.3M 144.6M 135.04M 141.94M
Deferred Revenue
n/a n/a 52.21M 50.85M
Short-Term Debt
1.2M 500K 465K 489K
Other Current Liabilities
147.2M 161.6M 117.44M 127.94M
Total Current Liabilities
467.8M 522.8M 568.71M 680.94M
Long-Term Debt
1.2B 1.2B 1.2B 10.51M
Other Long-Term Liabilities
177.2M 195M 195.93M 182.19M
Total Long-Term Liabilities
2.33B 3.04B 3.32B 3.43B
Total Liabilities
2.79B 3.56B 3.89B 4.11B
Total Debt
1.37B 1.41B 1.39B 223.38M
Common Stock
n/a n/a 3K 3K
Retained Earnings
7.42B 9.26B 9.9B 13.53B
Comprehensive Income
-538.2M -336M -466.82M -175.55M
Shareholders Equity
6.57B 8.74B 9.62B 13.69B
Total Investments
6.02B 8.9B 10.19B 14.79B